The Cancer Drug Development Forum (CDDF) is delighted to announce that a white paper, “Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action” has been published in European Journal of Cancer (Vol 209, September 2024).
This paper has been developed following the CDDF multi-stakeholder on The Critical Role of Biomarkers in Precision Oncology that took place in November 2023. The meeting generated insightful discussions among a group of diverse stakeholders, diving deep into key topics in the area.
🔶 Read the full article here: https://cddf.org/wp-content/uploads/2024/07/Empowering-effective-biomarker-driven-precision-oncology_2024.pdf
🔶Thank the following authors for their invaluable contributions:
Mark Lawler, Peter Keeling, Olga Kholmanskikh, Warnyta Minnaard, Heike Moehlig-Zuttermeister, Nicola Normanno, Reena Philip, Claudia Popp, Roberto Salgado, Ademi E. Santiago-Walker , Ana Trullas, Sahar B. van Waalwijk van Doorn-Khosrovani, Richard Vart, Jessica Vermeulen, Marianna Vitaloni, Jaap Verweij